Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 172,932 | 163,822 | 191,323 | 152,738 | 120,810 |
| Cost of Goods | 131,715 | 122,778 | 152,586 | 123,486 | 82,214 |
| Gross Profit | 41,217 | 41,044 | 38,737 | 29,252 | 38,596 |
| Operating Expenses | 43,488 | 39,741 | 44,735 | 45,399 | 32,344 |
| Operating Income | -1,556 | 2,081 | -5,412 | -15,661 | 6,466 |
| Interest Expense | 12,710 | 12,830 | 13,009 | 12,714 | 7,064 |
| Other Income | -633 | -793 | 5,930 | -549 | -5,661 |
| Pre-tax Income | -14,899 | -11,542 | -12,491 | -28,924 | -6,259 |
| Income Tax | -4,652 | -850 | 2,921 | -5,499 | 15,008 |
| Net Income Continuous | -10,247 | -10,692 | -15,412 | -23,425 | -21,267 |
| Net Income | $-10,247 | $-10,692 | $-15,412 | $-23,425 | $-21,267 |
| EPS Basic Total Ops | -0.24 | -0.25 | -0.36 | -0.57 | -0.61 |
| EPS Basic Continuous Ops | -0.24 | -0.25 | -0.37 | -0.57 | -0.61 |
| EPS Diluted Total Ops | -0.24 | -0.25 | -0.36 | -0.57 | -0.61 |
| EPS Diluted Continuous Ops | -0.24 | -0.25 | -0.37 | -0.57 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | 0.13 | 0.30 | 0.14 | 0.32 |
| EBITDA(a) | $18,303 | $20,897 | $15,854 | $1,360 | $15,392 |